Resources for coping with cancer during COVID-19. Learn More

Epigenetic biomarkers – Promising tools for prostate cancer

Speaker: Dr. Bharati Bapat
Original Date: Tuesday, January 26, 2016

Join Dr. Bapat as she describes:

  • What is Epigenetics
  • The interplay between epigenetics & genetics, and epigenetics & environment
  • What are different types of epigenetic biomarkers
  • How these markers will help prostate cancer patients

Dr. Bharati Bapat's Biography:

Dr. Bharati Bapat is Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto and has scientific appointments at the Lunenfeld-Tannenbaum Research Institute, Mount Sinai Hospital, and the Department of Laboratory Medicine and Pathology, University Health Network. 
Dr. Bapat’s research program is focused on translational genomics and epigenomics, specifically the discovery of cancer biomarkers, and understanding their role in cancer development.  Dr. Bapat is involved in several national and international collaborative prostate cancer research projects to develop biomarkers for personalized medicine using less invasive strategies to obtain patient samples. She is currently leading PCC funded Movember Translation Acceleration Grant (TAG) for validation of epigenetic biomarker panels for early detection of aggressive prostate cancer.  Dr. Bapat’s team is participating in Movember Global Action Plan (GAP) biomarker projects, aimed at making discoveries at a faster pace to help patients and their families.

About Expert Angle

Expert AngleExpert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.

Rock the Road Raffle 2021

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Canadian Cancer Society and Prostate Cancer Canada celebrate their amalgamation

February 3, 2020 (Toronto, ON) – On the eve of World Cancer Day, the Canadian Cancer Society (CCS) and Prostate Cancer Canada (PCC) have finalized their amalgamation.

1.5 million Canadian men over 50 now at unnecessary risk for prostate cancer

Toronto (ON) – September 26, 2019 – New findings released today in a Prostate Cancer Canada nationwide survey suggest 1.

$2 million invested in new prostate cancer research

Prostate Cancer Canada and Movember partner to fund ten research projects breaking new ground

Dream car draw a win for all Ontarians affected by prostate cancer

February 22, 2019 – TORONTO, ON – A dream came true today for Harold Mutter (ticket #19273), the lucky winner of a 2018 Acura NSX valued at more than $235,000 - the prize for Prostate Cancer Canada’s seventh Rock the Road Raffle.

Click here for news archive